Astrana Health (NASDAQ:ASTH) Shares Gap Up – Still a Buy?

Astrana Health, Inc. (NASDAQ:ASTHGet Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $26.00, but opened at $26.80. Astrana Health shares last traded at $27.3950, with a volume of 74,280 shares trading hands.

Wall Street Analyst Weigh In

ASTH has been the topic of several research analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Needham & Company LLC initiated coverage on shares of Astrana Health in a research note on Friday, December 12th. They set a “buy” rating and a $28.00 price objective on the stock. Truist Financial upped their price objective on shares of Astrana Health from $37.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, March 13th. BTIG Research decreased their price objective on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a research note on Monday, February 2nd. Finally, Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Astrana Health currently has an average rating of “Moderate Buy” and an average price target of $34.00.

Check Out Our Latest Analysis on ASTH

Astrana Health Price Performance

The stock’s 50-day moving average price is $22.77 and its 200-day moving average price is $25.29. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of 59.59 and a beta of 0.77. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.25.

Astrana Health (NASDAQ:ASTHGet Free Report) last announced its earnings results on Monday, March 2nd. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.39. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The company had revenue of $950.53 million for the quarter, compared to analyst estimates of $930.46 million. During the same period in the prior year, the business earned ($0.15) earnings per share. Astrana Health’s quarterly revenue was up 42.9% on a year-over-year basis. Equities research analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

A number of large investors have recently modified their holdings of ASTH. Signaturefd LLC lifted its position in shares of Astrana Health by 57.9% during the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares in the last quarter. Strs Ohio acquired a new position in shares of Astrana Health during the fourth quarter worth approximately $40,000. Covestor Ltd lifted its holdings in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after buying an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read More

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.